Biotech Values

[jq1234]

I don't think they are trying to get back into HCV game. They just hope VX135 would be able to combine with someone else's drugs, then out license it. If VRTX were to continue to develop HCV in house, I would have no interest in them. They are too far behind, it will be too costly/competitive at this point.